GRK6, a new therapeutic approach to alleviate L-dopa-induced dyskinesia

被引：1
|
作者：
Berthet, Amandine [1 ]
Bezard, Erwan [1 ]
机构：
[1] Univ Bordeaux 2, CNRS, Inst Neurosci Bordeaux, UMR 5227, F-33000 Bordeaux, France
来源：
M S-MEDECINE SCIENCES | 2010年 / 26卷 / 10期
关键词：
D O I：
10.1051/medsci/20102610800
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：800 / 803
页数：4
相关论文
共 50 条
  • [1] GRK6, a new therapeutic track to diminish L-dopa induced dyskinesia
    Berthet, Amandine
    Bezard, Erwan
    M S-MEDECINE SCIENCES, 2010, 26 (11): : 899 - 899
  • [2] Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease
    Ahmed, Mohamed R.
    Berthet, Amandine
    Bychkov, Evgeny
    Porras, Gregory
    Li, Qin
    Bioulac, Bernard H.
    Carl, Yonatan T.
    Bloch, Bertrand
    Kook, Seunghyi
    Aubert, Incarnation
    Dovero, Sandra
    Doudnikoff, Evelyne
    Gurevich, Vsevolod V.
    Gurevich, Eugenia V.
    Bezard, Erwan
    SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (28) : 28ra28
  • [3] Lentivirally-mediated overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease
    Ahmed, M. R.
    Berthet, A.
    Porras, G.
    Bychkov, E.
    Li, Q.
    Bioulac, B. H.
    Bloch, B.
    Koos, S.
    Aubert, I.
    Dovero, S.
    Doudnikoff, E.
    Gurevich, V. V.
    Gurevich, E. V.
    Bezard, E.
    MOVEMENT DISORDERS, 2009, 24 : S158 - S158
  • [4] L-DOPA-induced dyskinesia
    Derkinderen, P
    Vidailhet, M
    REVUE NEUROLOGIQUE, 2002, 158 : S92 - S101
  • [5] Dyskinesia: L-dopa-induced and tardive dyskinesia
    Rascol, O
    Fabre, N
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (06) : 313 - 323
  • [6] Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications
    Mellone, Manuela
    Gardoni, Fabrizio
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (08) : 1225 - 1236
  • [7] New insights into pathogenesis of L-DOPA-induced dyskinesia
    Zheng, Changqing
    Zhang, Feng
    NEUROTOXICOLOGY, 2021, 86 : 104 - 113
  • [8] Glutamatergic mechanisms in l-DOPA-induced dyskinesia and therapeutic implications
    Manuela Mellone
    Fabrizio Gardoni
    Journal of Neural Transmission, 2018, 125 : 1225 - 1236
  • [9] The pathophysiology of L-DOPA-induced dyskinesia
    Brotchie, JM
    MOVEMENT DISORDERS, 2004, 19 : S11 - S11
  • [10] Levetiracetam in L-dopa-induced dyskinesia
    Meco, G
    Fabrizio, E
    Epifanio, A
    Di Raimondo, G
    Vanacore, N
    Morgante, L
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (02) : 102 - 103
12345